CR Group L.P. - 27 Sep 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
10%+ Owner
Signature
/s/ Nathan D. Hukill, authorized signatory for CRG Partners III L.P., CRG Partners III Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P., and CRG Partners III (Cayman) Lev AIV I L.P.
Issuer symbol
TTOO
Transactions as of
27 Sep 2023
Net transactions value
-$2,271,957
Form type
4
Filing time
29 Sep 2023, 16:30:16 UTC
Previous filing
28 Sep 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Sale $458,304 -2,391,981 -46% $0.1916 2,858,980 27 Sep 2023 By CRG Partners III L.P. F1, F2
transaction TTOO Common Stock Sale $285,390 -1,489,512 -46% $0.1916 1,780,317 27 Sep 2023 By CRG Partners III ? Parallel Fund ?A? L.P. F1, F2
transaction TTOO Common Stock Sale $91,661 -478,396 -46% $0.1916 571,796 27 Sep 2023 By CRG Partners III (Cayman) Unlev AIV I L.P. F1, F2
transaction TTOO Common Stock Sale $310,644 -1,621,313 -46% $0.1916 1,937,852 27 Sep 2023 By CRG Partners III (Cayman) Lev AIV I L.P. F1, F2
transaction TTOO Common Stock Sale $450,289 -2,858,980 -100% $0.1575 0 28 Sep 2023 By CRG Partners III L.P. F2, F3
transaction TTOO Common Stock Sale $280,400 -1,780,317 -100% $0.1575 0 28 Sep 2023 By CRG Partners III ? Parallel Fund ?A? L.P. F2, F3
transaction TTOO Common Stock Sale $90,058 -571,796 -100% $0.1575 0 28 Sep 2023 By CRG Partners III (Cayman) Unlev AIV I L.P. F2, F3
transaction TTOO Common Stock Sale $305,212 -1,937,852 -100% $0.1575 0 28 Sep 2023 By CRG Partners III (Cayman) Lev AIV I L.P. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.17 to $0.2178, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
F2 CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.15 to $0.175, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.